Table 1 Characteristics of enrolled patients.
Sex | |
Male | 80 (59.3) |
Female | 55 (40.7) |
Age (median [range]) | 72.0 (42–95) |
Performance status at DS placement | |
0 | 20 (14.8) |
1 | 48 (35.6) |
2 | 46 (34.1) |
3 | 21 (15.6) |
NLR (median) | 4.6 |
GPS | |
0 | 20 (15) |
1 | 45 (33) |
2 | 70 (52) |
Cancer type | |
PDAC | 92 (68.1) |
Cholangiocarcinoma | 18 (13.3) |
Gall bladder cancer | 8 (5.9) |
Gastric cancer | 4 (3.0) |
Ampullary cancer | 3 (2.2) |
Duodenal cancer | 2 (1.5) |
Hepatocellular carcinoma | 2 (1.5) |
Colon cancer | 2 (1.5) |
Renal cell carcinoma | 2 (1.5) |
Neuroendocrine carcinoma | 1 (0.7) |
Breast cancer | 1 (0.7) |
Disease status | |
Locally advanced disease | 37 (27.4) |
Metastatic disease | 98 (72.6) |
Site of stricture | |
D1 | 64 (47.4) |
D2 | 36 (26.7) |
D3 | 35 (25.9) |
Type of DS | |
Niti-Sa | 59 (43.7) |
WallFlexb | 51 (37.8) |
Evolutionc | 25 (18.5) |
Presence of biliary stricture | 91 (67.4) |
Before duodenal stenosis | 59 (43.7) |
Simultaneously with duodenal stenosis | 24 (17.8) |
After duodenal stenosis | 8 (5.9) |
Oncological treatment before DS placement | 79 (58.5) |
Chemotherapy after DS placement | 48 (35.6) |
